PEDIATRICS Vol. 76 No. 4 October 1985, pp. 537-542
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Glode, M. P.
Right arrow Articles by Granoff, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Glode, M. P.
Right arrow Articles by Granoff, D. M.

Effect of Rifampin Chemoprophylaxis on Carriage Eradication and New Acquisition of Haemophilus influenzae Type b in Contacts

Mary P. Glode MD1, Robert S. Daum MD1, Eyla G. Boies MD1, Terri Lynn Ballard MT1, Martha Murray RN1, and Dan M. Granoff MD1

1 From the Departments of Pediatrics, The Children's Hospital and University of Colorado School of Medicine, Denver; and Tulane University, New Orleans; and the Edward Mallinkrodt Department of Pediatrics, Washington University School of Medicine, St Louis Children's Hospital, St Louis

We conducted a multicenter trial designed to assess the efficacy of three different drug regimens on eradication of Haemophilus influenzae type b (HIB) from the nasopharynx of household contacts of patients with invasive type b Haemophilus disease. The drug regimens studied were rifampin, 20 mg/kg, once daily for four days; rifampin, 10 mg/kg, twice a day for four days; and placebo, once daily for four days. Shortly after admission of the index patient to the hospital, 26% of 492 household contacts were found to be colonized with HIB. Both rifampin regimens eradicated carriage significantly better than placebo at 10 and 30 days (P = .001). However, among contacts whose cultures were initially negative, new acquisition of the organism occurred infrequently in this 30-day follow-up period regardless of the drug or placebo regimen prescribed. We also measured the concentration of anticapsular antibody in sera obtained from contacts younger than 6 years of age. Samples were obtained soon after admission of the index patient to the hospital and 30 days later. Several carriers younger than 2 years of age had low concentrations of antibody in both specimens. In contrast, nearly all carriers 2 to 5 years of age had high concentrations of antibody even in the first sample. Children who were not carriers usually had low antibody concentrations which did not increase during the period of observation. Our results suggest that most intrafamilial spread of HIB occurs prior to hospitalization of the index patient and stimulates immunity in contacts older than 2 years of age. Although rifampin decreases the carriage rate, new acquisition of HIB continues to occur at a low rate among contacts, even in those who receive rifampin prophylaxis.

Key Words: rifampin • chemoprophylaxis • Haemophilus influenzae type b

Submitted on August 17, 1984
Accepted on February 13, 1985




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
Q Zhang and A Finn
Mucosal immunology of vaccines against pathogenic nasopharyngeal bacteria
J. Clin. Pathol., October 1, 2004; 57(10): 1015 - 1021.
[Abstract] [Full Text] [PDF]